Biocon Q2

Net Exceptional Income At Rs 203 Cr
Cons EBITDA Margin At 26% Vs 24% (YoY)
Cons EBITDA +18% At Rs 222 Cr Vs Rs 188 Cr (YoY)
Cons Revenue +11% At Rs 861 Cr Vs Rs 750 Cr (YoY)
@CNBCTV18Live: Biocon Q2: Cons Net Profit At Rs 306 Cr Vs Rs 102 Cr (YoY)
@CNBCTV18Live: Biocon Q2: Cons EBITDA Margin At 26% Vs CNBC-TV18 Poll Of 21.81%
@CNBCTV18Live: Biocon Q2: Cons Net Profit At Rs 306 Cr Vs CNBC-TV18 Poll Of Rs 108 Cr